![]()
Disease Risk and Health DNA Test Market Scope:
Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
The Disease Risk and Health DNA Test market research reports indicate a growing demand for genetic testing due to increasing prevalence of chronic diseases. The market size is estimated to reach $10 billion by 2025, driven by advancements in technology and rising awareness about personalized healthcare. Companies are focusing on expanding their product portfolios to cater to the growing consumer base.
Companies Covered (Covid 19 Impact Covered)
◍ 23andMe
◍ MyHeritage
◍ LabCorp
◍ Myriad Genetics
◍ Ancestry.com
◍ Quest Diagnostics
◍ Gene By Gene
◍ DNA Diagnostics Center
◍ Invitae
◍ IntelliGenetics
◍ Ambry Genetics
◍ Living DNA
◍ EasyDNA
◍ Pathway Genomics
◍ Centrillion Technology
◍ Xcode
◍ Color Genomics
◍ Anglia DNA Services
The Disease Risk and Health DNA Test Market is competitive with companies such as 23andMe, MyHeritage, LabCorp, Myriad Genetics, and Ancestry.com leading the market. These companies offer genetic testing services for disease risk assessment and personalized health insights. They utilize advanced technology and research to provide accurate results, contributing to the growth of the market.
- LabCorp: $11.3 billion
- Myriad Genetics: $762.2 million
- MyHeritage: $100 million
Request Sample Report
By Application
◍ Online
◍ Offline
By Product
◍ Celiac Disease
◍ Parkinson Disease
◍ Alzheimer Disease
◍ Other
Request Sample Report
Request Sample Report
$ X Billion USD